Skip to main content
. 2021 Nov 29;247(8):672–682. doi: 10.1177/15353702211056272

Table 3.

Malaria, SMA, and mortality stratified by genotype/haplotype across the 36-month follow-up period.

Genotype/haplotype Amino acid Malaria episodes SMA episodes Mortality
2307C>G (rs2230199) Arg>Gly102 Total = 7717 Total = 444 Total = 99
 CC Arg/Arg102 6127 349 75
 CG Arg/Gly102 1465 81 21
 GG Gly/Gly102 125 14 3
34420G>A (rs11569534) Gly>Asp1224 Total = 7695 Total = 442 Total = 95
 GG Gly/Gly1224 6763 385 82
 GA Gly/Asp1224 494 36 7
 AA Asp/Asp1224 438 21 6
2307C>G/34420G>A Arg>Gly102/Gly>Asp1224 Total = 7755 Total = 447 Total = 100
 Non-CG Non-Arg102Non-Gly1224 682 46 9
 CG Arg102Gly1224 7073 401 91
 Non-CA Non-Arg102Asp1224 6838 390 87
 CA Arg102Asp1224 917 57 13
 Non-GG Non-Gly102Gly1224 6279 355 77
 GG Gly102Gly1224 1476 92 23
 Non-GA Non-Gly102Asp1224 7639 444 99
 GA Gly102Asp1224 116 3 1

Data are presented as the number of malaria and SMA episodes, and all-cause mortality stratified according genotypes and haplotypes during the 36-month follow-up period.